mRNA cancer vaccines are a relatively new class of vaccines, which combine the potential of mRNA to encode for almost any protein with an excellent safety profile and a flexible production process. mRNA therapy is a novel anticancer strategy based on in vitro transcription (IVT), which has potential for the treatment of malignant tumors. mRNA cancer vaccines use mRNA encoding tumor antigens or immunomodulatory molecules to deliver the corresponding proteins, combined with relevant delivery vectors and adjuvants, to induce antitumor responses mRNA vaccines represent an important class of cancer vaccines that are capable of encoding and expressing TAA (Tumor Associated Antigen), TSA (Tumor-specific antigens), and their associated cytokines. mRNA cancer vaccines can stimulate both humoral and cellular immunity, increasing the adaptability of these vaccines to different diseases and patients.

1 INTRODUCTION 

2 EXECUTIVE SUMMARY 

3 MARKET OUTLOOK

4 MRNA VACCINES & THERAPEUTICS TYPE ANALYSIS 

5 MRNA CANCER VACCINES & THERAPEUTICS MARKET END USER ANALYSIS 

6 MRNA CANCER VACCINES & THERAPEUTICS MARKET APPLICATION ANALYSIS

7 GLOBAL MRNA VACCINES & THERAPEUTICS REGIONAL ANALYSIS

8 MARKET PLAYERS